Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Abbott Laboratories

Abbott Laboratories (ABL.DE) Stock Overview

Explore Abbott Laboratories’s financial performance, market position, analyst ratings, and future outlook.

ABL.DE●XETRA
HealthcareMedical - Devices
€96.88
€1.80(1.89%)
German Market is Open · 14:10

Abbott Laboratories (ABL.DE)

Meyka AI Score

Z

Key Financials

Market Cap168B
P/E Ratio36.13
EPS (TTM)$3.83
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$96.32
3 Months$82.88
1 Year Target$77.60

ABL.DE Stock Analysis & Investment Overview (XETRA)

Our AI-powered analysis of Abbott Laboratories (XETRA: ABL.DE) gives investors deep insight into how the stock performs on the XETRA exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Abbott Laboratories's XETRA-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ABL.DE on the XETRA shows an RSI of 66.80, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $77.60 for the XETRA listing.

Key metrics behind Abbott Laboratories's XETRA-traded stock include a P/E ratio of 36.13 and a market capitalization of 168B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ABL.DE on the XETRA.

Price Performance (XETRA: ABL.DE)

1-Day Change
2.08%
5-Day Change
1.68%
1-Month Change
10.40%
3-Month Change
30.003%
6-Month Change
1.88%
Year-to-Date (YTD) Change
-8.03%
1-Year Change
-11.13%
3-Year Change
0.97%
5-Year Change
-8.82%
All-Time (Max) Change
237.37%

Contact Information

https://www.abbott.com
224 667 6100
100 Abbott Park Road, Abbott Park, IL, 60064-6400

Company Facts

1,150,000 Employees
IPO DateDec 20, 2007
CountryUS
Actively Trading

Frequently Asked Questions